AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...

A team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeutic ...

Microgravity is known to alter the muscles, bones, the immune system and cogni­tion, but little is known about its specific impact on the brain.

BioCentriq has entered into a long-term lease agreement with National Business Parks for a state-of-the-art cell therapy ...

Scientists sent stem-cell-derived brain organoids to the International Space Station (ISS) to study the effects of microgravity on brain development.

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine are closer to understanding what drives the ...

They grew their organoids in a lab using human induced pluripotent stem cells from healthy donors and patients with MS and ...

In April 2022, the U.S. Food and Drug Administration (FDA) granted the Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus Therapeutics plc for its lead gene therapy, obecabatagene ...

As astronauts venture further into space, their exposure to harmful radiation rises. Researchers from Columbia University are ...

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

Immunocore Holdings has dosed the first subject in a multicentre Phase I/II trial of IMC-R117C, a PIWIL1-targeted ...

Kura Oncology, Inc.'s partnership and promising AML treatment make it a top stock pick with significant upside potential for ...